CP and COVID-19: Our results also indicated the bacterial co-infection of COVID-19 in about 21% of patients (51 out of 245) using anti-CP and -MP serology, along with a number of other relevant parameters emerging from radiological imaging and laboratory tests (e.g., D-dimer and fibrinogen elevation vs. COVID-19 infection only).